Published in Cancer Res on July 01, 1987
Liposome: classification, preparation, and applications. Nanoscale Res Lett (2013) 1.41
Liposomes as nanomedical devices. Int J Nanomedicine (2015) 1.29
Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin. Br J Cancer (1991) 1.02
Mannose 6-phosphate receptor targeting and its applications in human diseases. Curr Med Chem (2007) 1.01
Diamagnetic chemical exchange saturation transfer (diaCEST) liposomes: physicochemical properties and imaging applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2013) 0.81
Drug and gene delivery across the blood-brain barrier with focused ultrasound. J Control Release (2015) 0.79
Assessment of collagen-induced arthritis using cyanine 5.5 conjugated with hydrophobically modified glycol chitosan nanoparticles: correlation with 18F-fluorodeoxyglucose positron emission tomography data. Korean J Radiol (2012) 0.79
Modulation of induced cytotoxicity of doxorubicin by using apoferritin and liposomal cages. Int J Mol Sci (2014) 0.79
In vivo stability of ester- and ether-linked phospholipid-containing liposomes as measured by perturbed angular correlation spectroscopy. Proc Natl Acad Sci U S A (1988) 0.78
Effect of lipid composition on activity of liposome-entrapped ampicillin against intracellular Listeria monocytogenes. Antimicrob Agents Chemother (1988) 0.78
Effect of liposomal celecoxib on proliferation of colon cancer cell and inhibition of DMBA-induced tumor in rat model. Cancer Nanotechnol (2011) 0.77
Serodiagnosis of Trichinella spiralis infections in pigs by enzyme-linked immunosorbent assays. Bull World Health Organ (1974) 2.59
Reliability of the enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of Trichinella spiralis infections in conventionally raised pigs. J Immunol Methods (1976) 2.09
Tumour-targeted nanomedicines: principles and practice. Br J Cancer (2008) 1.81
Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics. Clin Pharmacokinet (1992) 1.74
Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy. Curr Cancer Drug Targets (2009) 1.70
Direct measurement of microplates and its application to enzyme-linked immunosorbent assay. J Clin Microbiol (1976) 1.68
Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev (2001) 1.62
Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. J Pharmacol Exp Ther (2001) 1.55
Letter: Application of ELISA--enzyme linked immunosorbent assay--in the sero-diagnosis of amoebiasis. Trans R Soc Trop Med Hyg (1975) 1.44
An in vitro assay based on surface plasmon resonance to predict the in vivo circulation kinetics of liposomes. J Control Release (2011) 1.43
Free versus liposome-entrapped ampicillin in treatment of infection due to Listeria monocytogenes in normal and athymic (nude) mice. J Infect Dis (1985) 1.39
Intestinal phase of Trichinella spiralis in congenitally athymic (nude) mice. J Parasitol (1974) 1.37
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose. Biochim Biophys Acta (1997) 1.35
Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. Arthritis Rheum (2000) 1.32
Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J Pharmacol Exp Ther (2000) 1.32
Application of immunofluorescence and immunoenzyme methods in the serodiagnosis of Trichinella spiralis infection. Ann N Y Acad Sci (1975) 1.31
Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue. J Infect Dis (1993) 1.30
Chemical stability of liposomes: implications for their physical stability. Chem Phys Lipids (1993) 1.24
Air pollution is associated with increased level of exhaled nitric oxide in nonsmoking healthy subjects. Arch Environ Health (1999) 1.23
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy. Br J Cancer (2008) 1.23
Association between exhaled nitric oxide, ambient air pollution and respiratory health in school children. Int Arch Occup Environ Health (2002) 1.20
Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysis. Urol Res (1991) 1.17
Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin. Cancer Immunol Immunother (1991) 1.16
Adhesion molecules: a new target for immunoliposome-mediated drug delivery. FEBS Lett (1995) 1.16
Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer. Cancer Immunol Immunother (1992) 1.15
The athymic nude rat. III. Natural cell-mediated cytotoxicity. Clin Immunol Immunopathol (1980) 1.15
The effect of a water/organic solvent interface on the structural stability of lysozyme. J Control Release (2000) 1.14
Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim Biophys Acta (1993) 1.14
Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. J Immunol (1998) 1.12
Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies. J Liposome Res (2003) 1.11
Steric stabilization of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes mediates prolonged circulation and tumor targeting in mice. J Gene Med (2004) 1.10
Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann Rheum Dis (2004) 1.09
Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose. J Pharmacol Exp Ther (2000) 1.08
Mechanization of the enzyme-linked immunosorbent assay (ELISA) for large scale screening of sera. J Immunol Methods (1977) 1.07
Effect of liposome-entrapped ampicillin on survival of Listeria monocytogenes in murine peritoneal macrophages. Antimicrob Agents Chemother (1986) 1.06
Exhaled nitric oxide: a novel biomarker of adverse respiratory health effects in epidemiological studies. Arch Environ Health (2000) 1.06
2-(Dimethylamino)ethyl methacrylate based (co)polymers as gene transfer agents. J Control Release (1998) 1.04
Effect of DNA topology on the transfection efficiency of poly((2-dimethylamino)ethyl methacrylate)-plasmid complexes. J Control Release (1999) 1.03
Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies. J Antimicrob Chemother (2001) 1.03
Effect of size and serum proteins on transfection efficiency of poly ((2-dimethylamino)ethyl methacrylate)-plasmid nanoparticles. Pharm Res (1996) 1.01
Interaction of liposomes with Kupffer cells in vitro. Exp Cell Res (1984) 1.01
The role of protein charge in protein-lipid interactions. pH-dependent changes of the electrophoretic mobility of liposomes through adsorption of water-soluble, globular proteins. Biochemistry (1993) 1.00
Physical (in) stability of liposomes upon chemical hydrolysis: the role of lysophospholipids and fatty acids. Biochim Biophys Acta (1995) 1.00
Sterically stabilized liposomes labeled with indium-111 to image focal infection. J Nucl Med (1995) 0.99
Liposomes and ISCOMS as vaccine formulations. Biochim Biophys Acta (1995) 0.99
A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative. J Nucl Med (1999) 0.99
In vivo applications of PEG liposomes: unexpected observations. Crit Rev Ther Drug Carrier Syst (2001) 0.98
Bone targeting potential of bisphosphonate-targeted liposomes. Preparation, characterization and hydroxyapatite binding in vitro. Int J Pharm (2006) 0.98
Examining the role of Rac1 in tumor angiogenesis and growth: a clinically relevant RNAi-mediated approach. Angiogenesis (2011) 0.98
The fate of poly(2-dimethyl amino ethyl)methacrylate-based polyplexes after intravenous administration. Int J Pharm (2001) 0.97
Optimization of poly(amido amine)s as vectors for siRNA delivery. J Control Release (2010) 0.97
Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: influence of liposome characteristics. Biochim Biophys Acta (1999) 0.96
99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation. J Nucl Med (2000) 0.96
On the structure of immune-stimulating saponin-lipid complexes (iscoms). Biochim Biophys Acta (1991) 0.96
Micelles based on HPMA copolymers. Adv Drug Deliv Rev (2009) 0.96
Possible immunosuppressive effect of Corynebacterium parvum on infection with Trichinella spiralis. Nat New Biol (1973) 0.96
Liposomes as carriers of the antiretroviral agent dideoxycytidine-5'-triphosphate. Int J Pharm (1999) 0.95
Requirements for cellular co-trafficking of factor VIII and von Willebrand factor to Weibel-Palade bodies. J Thromb Haemost (2007) 0.95
Host factors influencing the preferential localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue. Pharm Res (2001) 0.94
Immunogenic activity of gonococcal protein I in mice with three different lipoidal adjuvants delivered in liposomes and in complexes. Infect Immun (1986) 0.94
The preparation of tissue-type Plasminogen Activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage. J Drug Target (1995) 0.94
Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis. Biochim Biophys Acta (1999) 0.94
Ozone-induced inflammation assessed in sputum and bronchial lavage fluid from asthmatics: a new noninvasive tool in epidemiologic studies on air pollution and asthma. Free Radic Biol Med (1999) 0.93
Liposomes as sustained release system for human interferon-gamma: biopharmaceutical aspects. Biochim Biophys Acta (2001) 0.93
Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques. J Control Release (2000) 0.92
Cellular uptake of liposomes targeted to intercellular adhesion molecule-1 (ICAM-1) on bronchial epithelial cells. Biochim Biophys Acta (1999) 0.92
Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes. J Control Release (2003) 0.91
Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes. J Nucl Med (1996) 0.91
Schistosoma mansoni: comparison of the immunoperoxidase techniques, DASS and ELISA, for human diagnosis. Exp Parasitol (1977) 0.91
In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide. Cancer Res (1986) 0.91
Intrahepatic distribution of small unilamellar liposomes as a function of liposomal lipid composition. Biochim Biophys Acta (1986) 0.91
Chemical hydrolysis of phospholipids. J Pharm Sci (1995) 0.90
Immune biomarkers in relation to exposure to particulate matter: a cross-sectional survey in 17 cities of Central Europe. Inhal Toxicol (2000) 0.90
Uptake and intracellular processing of targeted and nontargeted liposomes by rat Kupffer cells in vivo and in vitro. Ann N Y Acad Sci (1985) 0.89
Hydrolysis of saturated soybean phosphatidylcholine in aqueous liposome dispersions. J Pharm Sci (1993) 0.89
Ovalbumin immunity in the rat: simultaneous testing of IgM, IgG and IgE response measured by ELISA and delayed-type hypersensitivity. Scand J Immunol (1980) 0.88
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: III. Influence of surface modification with poly(ethyleneglycol). Pharm Res (1997) 0.88
Citrullinemia, report of a case, with studies on antenatal diagnosis. Pediatr Res (1973) 0.88
The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparation. Biochim Biophys Acta (1985) 0.88
Short term stability of freeze-dried, lyoprotected liposomes. J Control Release (1999) 0.88
Preparation of liposomes via detergent removal from mixed micelles by dilution. The effect of bilayer composition and process parameters on liposome characteristics. Pharm Weekbl Sci (1986) 0.88
Radiopharmaceuticals for scintigraphic imaging of infection and inflammation. Inflamm Res (2001) 0.88
Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells. Adv Drug Deliv Rev (2010) 0.88
Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma. Cancer Res (1989) 0.87
The prevalence of allergic sensitisation in immigrant children in The Netherlands. Int Arch Allergy Immunol (2004) 0.87
The use of aqueous PEG/dextran phase separation for the preparation of dextran microspheres. Int J Pharm (1999) 0.87
Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-Guerin. In Vivo (1992) 0.86